DaVita (NYSE:DVA) Issues FY 2025 Earnings Guidance

Key Points

• DaVita has issued its FY 2025 earnings guidance, projecting an EPS of 10.200-11.300, compared to a consensus estimate of 10.733.
• The stock's current consensus rating is a "Hold" with a price target of $167.40, following recent changes from analysts including a downgrade by Truist and an upgrade by Wall Street Zen.
• DaVita's shares are currently trading at $140.98, with a market capitalization of $10.64 billion and a P/E ratio of 13.97.

DaVita (NYSE:DVA - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 10.200-11.300 for the period, compared to the consensus EPS estimate of 10.733. The company issued revenue guidance of -.

Analyst Ratings Changes

Several research firms have recently weighed in on DVA. Truist Financial reduced their price objective on DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a research note on Monday, May 19th. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a research note on Friday, April 25th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $167.40.

DaVita Price Performance

Shares of DVA traded up $1.46 during mid-day trading on Tuesday, reaching $140.98. The company had a trading volume of 1,224,624 shares, compared to its average volume of 853,606. The company's 50-day moving average is $140.47 and its 200-day moving average is $147.52. DaVita has a twelve month low of $131.76 and a twelve month high of $179.60. The company has a market capitalization of $10.64 billion, a P/E ratio of 13.97, a P/E/G ratio of 0.96 and a beta of 1.09. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20.

DaVita (NYSE:DVA - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, topping the consensus estimate of $2.70 by $0.25. DaVita had a return on equity of 176.11% and a net margin of 6.63%. On average, equities analysts anticipate that DaVita will post 10.76 EPS for the current year.

Insiders Place Their Bets

In other DaVita news, insider James O. Hearty sold 2,351 shares of DaVita stock in a transaction dated Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the transaction, the insider owned 26,038 shares in the company, valued at approximately $3,905,700. The trade was a 8.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 2.00% of the stock is owned by insiders.

Institutional Inflows and Outflows

An institutional investor recently raised its position in DaVita stock. NewEdge Advisors LLC increased its stake in DaVita Inc. (NYSE:DVA - Free Report) by 20.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 511 shares of the company's stock after buying an additional 88 shares during the period. NewEdge Advisors LLC's holdings in DaVita were worth $78,000 at the end of the most recent reporting period. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.